Danaher (DHR) Income from Continuing Operations (2009 - 2026)
Danaher (DHR) posted Income from Continuing Operations of $870.0 million for Q2 2026, down 15.45% on a QoQ basis from $1.0 billion in Q1 2026, and up 56.76% year-over-year from $555.0 million in Q2 2025.
Analysis
Danaher (DHR) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Danaher has reported Income from Continuing Operations for 18 years, with the latest figure at $870.0 million in Q2 2026.
- On a quarterly basis, Income from Continuing Operations rose 56.76% year-over-year to $870.0 million in Q2 2026; TTM through Jun 2026 was $4.0 billion, a 16.91% increase from a year earlier, with the FY2025 full-year figure at $3.6 billion, down 7.67% from the prior year.
- Income from Continuing Operations was $870.0 million for Q2 2026 at Danaher, down from $1.0 billion in the prior quarter.
- The five-year high for Income from Continuing Operations was $1.7 billion in Q2 2022, with the low at $555.0 million in Q2 2025.
- Average Income from Continuing Operations over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Income from Continuing Operations tumbled 45.24% in 2023, then soared 56.76% in 2026.
- Over 5 years, Income from Continuing Operations stood at $1.4 billion in 2022, then declined by 17.02% to $1.1 billion in 2023, then decreased by 3.12% to $1.1 billion in 2024, then advanced by 8.93% to $1.2 billion in 2025, then declined by 26.46% to $870.0 million in 2026.
- The last three Income from Continuing Operations figures came in at $870.0 million (Q2 2026), $1.0 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 362.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 207.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 53.48 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 54.62 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 371.40 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 5.01 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -17.93 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -65.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 26, 2026 | 870.00 Mn |
| Mar 27, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.18 Bn |
| Sep 26, 2025 | 908.00 Mn |
| Jun 27, 2025 | 555.00 Mn |
| Mar 28, 2025 | 954.00 Mn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 27, 2024 | 818.00 Mn |
| Jun 28, 2024 | 907.00 Mn |
| Mar 29, 2024 | 1.09 Bn |
| Dec 31, 2023 | 1.12 Bn |
| Sep 29, 2023 | 940.00 Mn |
| Jun 30, 2023 | 920.00 Mn |
| Mar 31, 2023 | 1.24 Bn |
| Dec 31, 2022 | 1.35 Bn |
| Sep 30, 2022 | 1.57 Bn |
| Jul 1, 2022 | 1.68 Bn |
| Apr 1, 2022 | 1.73 Bn |
| Dec 31, 2021 | 888.00 Mn |
| Oct 1, 2021 | 1.16 Bn |